Radius Health, Inc.
DelistedCIK 1428522fmd_1ACV49JYZBDB6RC3SBQVZZFEYVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2022, 51 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | 99 | 173 | 239 | 230 |
| Cost of revenue | – | – | – | – | 0 | 1 | 8 | – | – | – |
| Gross profit | – | – | – | – | – | – | 92 | – | – | – |
| Research and development | 55 | 61 | 46 | 68 | 107 | 83 | 100 | 117 | 160 | 135 |
| Selling, general and administrative | – | – | – | – | – | – | – | 153 | 144 | 131 |
| Operating income | (64) | (67) | (59) | (99) | (185) | (249) | (204) | (112) | (82) | (54) |
| Interest expense | 3 | 2 | 2 | 2 | 0 | 8 | 23 | 25 | 28 | 18 |
| Interest and investment income | 0 | 0 | 0 | 1 | 2 | 3 | 6 | 4 | 1 | 0 |
| Other non-operating income (expense) | (2) | 9 | (1) | (0) | (0) | (0) | 0 | 0 | (0) | 0 |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (69) | (61) | (62) | (102) | (183) | (254) | (221) | (133) | (109) | (70) |
| Net income to common shareholders | (83) | (78) | (71) | (102) | (183) | (254) | (221) | (133) | (109) | (70) |